Dechert Advises Havea in its Exclusive Negotiations for the Acquisition of Biocyte

Dechert LLP advised Havea in connection with its exclusive negotiations for the acquisition of Biocyte, a French laboratory that is a pioneer in nutricosmetics.

This acquisition will allow Havea, a major player in the food supplements industry, to continue its growth in China, where it is already present through the Vitavea and Biolane brands.

The Dechert team was led by corporate/M&A partner Ermine Bolot and regulatory partner Sophie Pelé, and coordinated by Alain Decombe. The team also included corporate/M&A associates Ernest Yan and Léa Kemayou; pharma regulatory associate Margaux Lasseigne; labour national partner Thibault Meiers and associate Maëlle Chausse; and antitrust national partner Marion Provost and associate Marion Lécole.

About Dechert

Dechert is a leading global law firm with 21 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.

With 70 lawyers, the Paris office is a key component of the firm's strategy in Europe and is active in antitrust/competition, corporate and securities, financial services matters, financing, intellectual property, international arbitration, investigations and compliance, labor and employment, litigation, regulatory and tax.

Dechert’s life sciences team in France represents companies ranging from multinational giants to emerging companies involving all aspects of the life sciences industry, including pharmaceuticals, biotechnology, drug discovery, genomics, biopharmaceuticals, diagnostics, medical devices and health care. We also assist investment funds with life sciences investments. Read more »